REG - GSK PLC - Director/PDMR Shareholding

GSKAnnouncement

Yesterday 15:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260428:nRSb2566Ca&default-theme=true

RNS Number : 2566C  GSK PLC  28 April 2026

GSK plc (the 'Company')

Vesting of 2023 Performance Share Plan Award

This notification sets out the vesting details of a conditional share award
made under the GSK 2017 Performance Share Plan ('PSP') to the Chief Financial
Officer (CFO) on 27 April 2023 upon her joining GSK as CFO Designate.

Following the third anniversary of the grant, this 2023 PSP award has now
vested on the same basis as the 2023 PSP awards which vested on 13 February
2026, with 82% vesting and 18% lapsed. Details of the performance measure
outcomes and vesting levels are set out in the announcement of 17 February
2026
(https://otp.tools.investis.com/clients/uk/gsk/rns/regulatory-story.aspx?cid=410&newsid=2034514)
.

For the CFO, the vested shares are subject to an additional two-year holding
period.

The notification that follows details the number of shares that vested under
this 2023 PSP award for the CFO, including dividends accrued, on 27 April
2026. The balance of the award has lapsed.

The closing price of Ordinary Shares of GSK plc on the vesting date was
£20.16.

Transaction notification

 

 1.  Details of PDMR/person closely associated with them ('PCA')
 a)  Name                                     Julie Brown
 b)  Position/status                          Chief Financial Officer
 c)  Initial notification/                    Initial notification

     amendment
 2.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     GSK plc
 b)  LEI                                      5493000HZTVUYLO1D793
 3.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transaction(s) has been conducted
 a)  Description of the financial instrument  Ordinary Shares of 31 ¼ pence each ('Ordinary Shares')

ISIN: GB00BN7SWP63
 b)  Nature of the transaction                The vesting of awards granted in 2023 under the Company's 2017 Performance
                                              Share Plan
 c)  Price(s) and volume(s)                                        Price(s)             Volume(s)
                                                                   £0.00                243,880

 d)  Aggregated information                   N/A (single transaction)

     Aggregated volume Price
 e)  Date of the transaction                  2026-04-27
 f)  Place of the transaction                 N/A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHSEMFEAEMSEDL



            Copyright 2019 Regulatory News Service, all rights reserved